The University of Manchester: European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates.
Data-sharing agreement from NHS Digital registers of approved data releases, 2014–2019. Evidence status: source reported.
- Organisation
- The University of Manchester
- Source reference
- DARS-NIC-148264-XXC29-v0.0
- Jurisdiction
- England
- Licence
- Open Government Licence v3.0, subject to NHS England terms and exclusions
European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates. Title appearing in all publications: the European Male Ageing study (EMAS). Identify and quantify any disparities in the prevalence, incidence, nature and severity of symptoms and disabilities of ageing in the general male population from different regions of the EU. Explain regional differences in the health status of ageing men on the basis of the decline in endocrine (hormonal) functions. Elucidate the relationships between cl
- Register reference
- DARS-NIC-148264-XXC29-v0.0
- Agreement period
- not published to no end date published
- For commercial purposes (as marked in the register)
- Not stated
- Release files listed by NHS England
- 6
Data approved
- MRIS - Cause of Death Report
- MRIS - Cohort Event Notification Report
Objective, as published
European Male Ageing study: Prevalence, Incidence and Geographical Distribution of Symptoms of Ageing in Men and their Endocrine, Genetic and Psychosocial Correlates. Title appearing in all publications: the European Male Ageing study (EMAS). Identify and quantify any disparities in the prevalence, incidence, nature and severity of symptoms and disabilities of ageing in the general male population from different regions of the EU. Explain regional differences in the health status of ageing men on the basis of the decline in endocrine (hormonal) functions. Elucidate the relationships between clinical features associated with ageing and the attendant hormonal changes. Characterise threshold hormone levels for symptomatic and asymptomatic deficiency states in elderly men (i.e. identify the low hormone levels at which older men may become unwell or impaired). Identify potentially modifiable region-specific and/or race/ethnicity-specific risk factors for the evolution and progression of symptoms, disabilities, changes in body composition and hormonal decline associated with ageing in the EU. Inform European policy-makers and industry and formulate recommendations for screening, prevention, diagnosis and treatment of individual functional disabilities or an ageing-related clinical syndrome in men if it is found to exist.
Source: https://webarchive.nationalarchives.gov.uk/ukgwa/2019/http://content.digital.nhs.uk/media/23167/Data-Release-Register-September---November-2016/xls/Data_Release_Register__September_-_November_2016.xlsx. Captured 2026-10-30.
Limitations: Agreement as recorded in an NHS Digital register of approved data releases (2014–2019), retrieved from the UK Government Web Archive. That register lists releases made in its period and the agreement's purpose statement as it then stood; it gives no agreement dates, and the agreement may have changed since. Imported only where a paper quotes a reference no current register holds.